451 related articles for article (PubMed ID: 16953273)
1. Amplified anticoagulant activity of tissue factor-targeted thrombomodulin: in-vivo validation of a tissue factor-neutralizing antibody fused to soluble thrombomodulin.
Wang YX; Wu C; Vincelette J; Martin-McNulty B; Alexander S; Larsen B; Light DR; McLean K
Thromb Haemost; 2006 Sep; 96(3):317-24. PubMed ID: 16953273
[TBL] [Abstract][Full Text] [Related]
2. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
3. Soluble thrombomodulin purified from human urine exhibits a potent anticoagulant effect in vitro and in vivo.
Takahashi Y; Hosaka Y; Niina H; Nagasawa K; Naotsuka M; Sakai K; Uemura A
Thromb Haemost; 1995 May; 73(5):805-11. PubMed ID: 7482407
[TBL] [Abstract][Full Text] [Related]
4. Potent bifunctional anticoagulants: Kunitz domain-tissue factor fusion proteins.
Lee GF; Lazarus RA; Kelley RF
Biochemistry; 1997 May; 36(19):5607-11. PubMed ID: 9153400
[TBL] [Abstract][Full Text] [Related]
5. A novel anti-tissue factor monoclonal antibody with anticoagulant potency derived from synthesized multiple antigenic peptide through blocking FX combination with TF.
Peng ZC; Cai X; Zhang YG; Kong DS; Guo HS; Liang W; Tang QQ; Song HY; Ma D
Thromb Res; 2007; 121(1):85-93. PubMed ID: 17573098
[TBL] [Abstract][Full Text] [Related]
6. Epitope location on tissue factor determines the anticoagulant potency of monoclonal anti-tissue factor antibodies.
Kirchhofer D; Moran P; Chiang N; Kim J; Riederer MA; Eigenbrot C; Kelley RF
Thromb Haemost; 2000 Dec; 84(6):1072-81. PubMed ID: 11154116
[TBL] [Abstract][Full Text] [Related]
7. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro.
Moore KL; Andreoli SP; Esmon NL; Esmon CT; Bang NU
J Clin Invest; 1987 Jan; 79(1):124-30. PubMed ID: 3025256
[TBL] [Abstract][Full Text] [Related]
8. Evidence that the protein C activation pathway amplifies the inhibition of thrombin generation by recombinant human thrombomodulin in plasma.
Ohishi R; Watanabe N; Aritomi M; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
Thromb Haemost; 1993 Sep; 70(3):423-6. PubMed ID: 8259542
[TBL] [Abstract][Full Text] [Related]
9. Membrane-mimetic films containing thrombomodulin and heparin inhibit tissue factor-induced thrombin generation in a flow model.
Tseng PY; Rele SS; Sun XL; Chaikof EL
Biomaterials; 2006 Apr; 27(12):2637-50. PubMed ID: 16376423
[TBL] [Abstract][Full Text] [Related]
10. Increased anticoagulant activity of recombinant thrombomodulin modified with glycosaminoglycan.
Edano T; Inoue K; Yoshizaki H; Yamamoto S; Komine N; Tabunoki H; Sawada H; Koshi T; Murakami A; Wada Y; Ohkuchi M
Biol Pharm Bull; 1998 Apr; 21(4):375-81. PubMed ID: 9586576
[TBL] [Abstract][Full Text] [Related]
11. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
Arnold CS; Parker C; Upshaw R; Prydz H; Chand P; Kotian P; Bantia S; Babu YS
Thromb Res; 2006; 117(3):343-9. PubMed ID: 16378835
[TBL] [Abstract][Full Text] [Related]
12. Covalently immobilized thrombomodulin inhibits coagulation and complement activation of artificial surfaces in vitro.
Sperling C; Salchert K; Streller U; Werner C
Biomaterials; 2004 Sep; 25(21):5101-13. PubMed ID: 15109834
[TBL] [Abstract][Full Text] [Related]
13. The glycosaminoglycan of recombinant human soluble thrombomodulin affects antithrombotic activity in a rat model of tissue factor-induced disseminated intravascular coagulation.
Nawa K; Itani T; Ono M; Sakano K; Marumoto Y; Iwamoto M
Thromb Haemost; 1992 Mar; 67(3):366-70. PubMed ID: 1322570
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human soluble thrombomodulin reduces endotoxin-induced pulmonary vascular injury via protein C activation in rats.
Uchiba M; Okajima K; Murakami K; Nawa K; Okabe H; Takatsuki K
Thromb Haemost; 1995 Nov; 74(5):1265-70. PubMed ID: 8607107
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effect of recombinant human soluble thrombomodulin on initiation and extension of coagulation--a comparison with other anticoagulants.
Mohri M; Sugimoto E; Sata M; Asano T
Thromb Haemost; 1999 Dec; 82(6):1687-93. PubMed ID: 10613656
[TBL] [Abstract][Full Text] [Related]
16. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic effects of recombinant human soluble thrombomodulin in a rat model of vascular shunt thrombosis.
Ono M; Nawa K; Marumoto Y
Thromb Haemost; 1994 Sep; 72(3):421-5. PubMed ID: 7855794
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor/factor VIIa pathway mediates coagulation activation in induced-heat stroke in the baboon.
Bouchama A; Al-Mohanna F; Assad L; Baturcam E; Eldali A; Owaidah T; Dehbi M
Crit Care Med; 2012 Apr; 40(4):1229-36. PubMed ID: 22080642
[TBL] [Abstract][Full Text] [Related]
19. In vitro anticoagulant properties of a minimum functional fragment of human thrombomodulin and in vivo demonstration of its benefit as an anticoagulant in extracorporeal circulation using a monkey model.
Suzuki M; Mohri M; Yamamoto S
Thromb Haemost; 1998 Feb; 79(2):417-22. PubMed ID: 9493601
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection by recombinant thrombomodulin.
Taoka Y; Okajima K; Uchiba M; Johno M
Thromb Haemost; 2000 Mar; 83(3):462-8. PubMed ID: 10744154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
